NCT01273610 · Interventional trial
Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer
Overall registry status Active not recruiting
Phase 2
Conditions Breast Neoplasms, Geriatric Health Services, HER2/Neu Positive
Delaware Valley sites
- Thomas Jefferson University · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory